Ecovyst (ECVT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Q2 2024 sales were $182.8M, down 0.7% year-over-year, mainly due to lower average selling prices in Ecoservices, partially offset by higher volumes in regeneration services and advanced silicas.
Net income for Q2 2024 was $8.3M (4.5% margin), a 68.2% decrease compared to Q2 2023, driven by lower gross profit, higher interest expense, and reduced Zeolyst JV earnings.
Adjusted EBITDA for Q2 2024 was $56.9M, down 28% year-over-year, reflecting unfavorable net pricing, higher maintenance costs, and lower Zeolyst JV earnings.
Strategic initiatives included an equity investment in Pajarito Powder, completion of major turnarounds, and a term loan amendment extending maturity to 2031 and reducing interest rate spread.
Maintained balanced capital allocation with $5M in share repurchases and investments to expand advanced materials capabilities.
Financial highlights
Q2 2024 GAAP sales were $182.8M, down 0.7% year-over-year; Zeolyst JV sales fell 35.1% to $29.0M.
Net income was $8.3M, a 68.2% decrease compared to Q2 2023; net income margin dropped to 4.5%.
Adjusted EBITDA was $56.9M, down 28.2% year-over-year; margin was 26.8%.
Adjusted Free Cash Flow for the first half was $14.4M, up from $1.9M in the prior year period.
Available liquidity as of June 30, 2024, was $156M; cash and cash equivalents were $83.3M.
Outlook and guidance
Full-year 2024 sales guidance revised to $700M–$740M (from $715M–$755M); Zeolyst JV sales outlook lowered to $115M–$135M.
Adjusted EBITDA guidance for 2024 reduced to $230M–$245M (prior: $255M–$275M); Q3 2024 Adjusted EBITDA expected at $58M–$65M.
Free cash flow guidance for 2024 set at $75M–$85M; adjusted net income expected at $53M–$74M, with EPS of $0.45–$0.63.
Guidance reflects anticipated softening in sustainable fuel and emission control demand, and cautious outlook for industrial demand.
Latest events from Ecovyst
- Q2 2026 sales up 42%, net income doubled, and guidance raised after Calabrian acquisition.ECVT
Q2 2026 - Q1 2025 sales reached $162 million with strong catalyst growth and stable leverage.ECVT
BMO Chemicals 2025 Conference presentation - Q1 2024 delivered higher margins, strong cash flow, and growth in sustainable catalyst markets.ECVT
2024 Wells Fargo Industrials Conference presentation - Q2 2025 sales rose, margins faced pressure, and strategic focus remains on sustainable growth.ECVT
Jefferies 2025 Industrials Conference presentation - Q3 2025 delivered robust sales and EBITDA, with post-divestiture leverage expected below 1.5x.ECVT
Citi 2025 Basic Materials Conference presentation - Q1 2026 saw robust sales and margin growth, supported by strategic expansion and strong cash flow.ECVT
BMO Chemicals 2026 Conference presentation - Q1 2025 sales stable, margins pressured, Zeolyst JV drives catalyst segment growth.ECVT
DB 15th Annual Global Industrials, Materials & Building Products Conference presentation - Q1 2026 delivered strong sales and EBITDA growth, driven by expanded sulfur solutions and robust demand.ECVT
Wells Fargo Industrials Conference presentation - Robust sales, cash flow, and margins with stable leverage and a focus on sustainability.ECVT
Bank of America Securities 2024 Leveraged Finance Conference